Revenue: As of FY2025 Q3, the actual value is USD 1.173 M.EPS: As of FY2025 Q3, the actual value is USD -0.4.EBIT: As of FY2025 Q3, the actual value is USD -3.445 M.<h3>Segment Revenue</h3><ul><li>Revenue: For the three months ended September 30, 2025, revenue was $1,173,000, an increase from $887,000 in the same period in 2024. For the nine months ended September 30, 2025, revenue was $2,463,000, slightly down from $2,507,000 in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Net Loss: The net loss for the three months ended September 30, 2025, was $3,339,000, compared to $3,184,000 in 2024. For the nine months ended September 30, 2025, the net loss was $9,724,000, compared to $10,586,000 in 2024.</li><li>Gross Profit: Gross profit for the three months ended September 30, 2025, was $773,000, up from $418,000 in 2024. For the nine months ended September 30, 2025, gross profit was $1,341,000, compared to $1,358,000 in 2024.</li><li>Operating Expenses: Total operating expenses for the three months ended September 30, 2025, were $4,165,000, up from $3,633,000 in 2024. For the nine months ended September 30, 2025, operating expenses were $11,267,000, down from $11,951,000 in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: Net cash used in operating activities for the nine months ended September 30, 2025, was $8,521,000, compared to $7,101,000 in 2024.</li><li>Investing Cash Flow: Cash used in investing activities for the nine months ended September 30, 2025, was $831,000, compared to $223,000 in 2024.</li><li>Financing Cash Flow: Net cash provided by financing activities for the nine months ended September 30, 2025, was $6,259,000, compared to $14,012,000 in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Acquisition Costs: The company incurred approximately $779,000 in acquisition-related costs during the period.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to continue investing in the commercialization of The Catamaran System and the SImmetry SI Joint Fusion System, with a focus on increasing sales and marketing efforts to drive revenue growth.</li><li>Non-Core Business: The company completed the acquisition of SiVantage, Inc. and SIMPL Medical, LLC, which are expected to expand its product offerings and market reach.</li><li>Priority: The company is focused on raising additional capital through public or private equity offerings, debt financings, and collaborations to support its operations and growth strategy.</li></ul>

TENON MEDICAL INC C/WTS 16/06/2028 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 1.173 M